XML 15 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Current assets    
Cash and cash equivalents $ 30,607,868 $ 50,234,871
Marketable securities 48,556,558 37,762,439
Restricted cash 100,000 100,000
Prepaid expenses and other current assets 1,054,034 1,921,050
Total current assets 80,318,460 90,018,360
Equipment, net 29,111 33,478
Other noncurrent assets 14,808 14,808
Operating lease right-of-use assets 371,370  
In-process research and development 34,200,000 34,200,000
Goodwill 14,869,399 14,869,399
Total assets 129,803,148 139,136,045
Current liabilities    
Accounts payable 3,025,563 1,799,666
Accrued expenses and other current liabilities 3,720,955 1,809,532
Operating leases 156,159  
Total current liabilities 6,902,677 3,609,198
Deferred taxes 4,057,488 4,057,488
Deferred revenue 41,175,600 41,175,600
Noncurrent operating leases 243,115  
Other noncurrent liabilities   28,990
Total liabilities 52,378,880 48,871,276
Commitments and contingencies
Stockholders’ equity    
Preferred stock; $0.0001 par value; 100,000,000 shares authorized; none issued or outstanding as of March 31, 2019 and December 31, 2018, respectively
Common stock; $0.0001 par value; 125,000,000 shares authorized; 39,025,471 and 38,937,971 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively 3,903 3,894
Additional paid-in capital 307,800,293 304,813,603
Accumulated deficit (230,379,928) (214,552,728)
Total stockholders’ equity 77,424,268 90,264,769
Total liabilities and stockholders’ equity $ 129,803,148 $ 139,136,045